0 false false false false false false false false false false true false false false false false false No description of principal activity 2022-05-01 Sage Accounts Production Advanced 2023 - FRS102_2023 145,080 145,080 17,297 260 17,557 16,574 426 17,000 557 723 xbrli:pure xbrli:shares iso4217:GBP 07141314 2022-05-01 2023-04-30 07141314 2023-04-30 07141314 2022-04-30 07141314 2021-05-01 2022-04-30 07141314 2022-04-30 07141314 2021-04-30 07141314 core:NetGoodwill 2022-05-01 2023-04-30 07141314 bus:RegisteredOffice 2022-05-01 2023-04-30 07141314 bus:LeadAgentIfApplicable 2022-05-01 2023-04-30 07141314 bus:Director1 2022-05-01 2023-04-30 07141314 bus:Director2 2022-05-01 2023-04-30 07141314 core:NetGoodwill 2023-04-30 07141314 core:WithinOneYear 2023-04-30 07141314 core:WithinOneYear 2022-04-30 07141314 core:ShareCapital 2023-04-30 07141314 core:ShareCapital 2022-04-30 07141314 core:RetainedEarningsAccumulatedLosses 2023-04-30 07141314 core:RetainedEarningsAccumulatedLosses 2022-04-30 07141314 bus:SmallEntities 2022-05-01 2023-04-30 07141314 bus:AuditExempt-NoAccountantsReport 2022-05-01 2023-04-30 07141314 bus:SmallCompaniesRegimeForAccounts 2022-05-01 2023-04-30 07141314 bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 07141314 bus:FullAccounts 2022-05-01 2023-04-30 07141314 core:OfficeEquipment 2022-05-01 2023-04-30 07141314 core:OfficeEquipment 2022-04-30 07141314 core:OfficeEquipment 2023-04-30
COMPANY REGISTRATION NUMBER: 07141314
GYNICARE LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 April 2023
GYNICARE LIMITED
FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2023
Contents
Page
Officers and professional advisers
1
Statement of financial position
2
Notes to the financial statements
3
GYNICARE LIMITED
OFFICERS AND PROFESSIONAL ADVISERS
The board of directors
Dr N S Nicholas
Mrs P Nicholas
Registered office
Lynton House
7 - 12 Tavistock Square
London
WC1H 9BQ
Accountants
TC BSG Valentine Limited
Accountants
Lynton House
7-12 Tavistock Square
London
WC1H 9BQ
GYNICARE LIMITED
STATEMENT OF FINANCIAL POSITION
30 April 2023
2023
2022
Note
£
£
£
£
FIXED ASSETS
Tangible assets
6
557
723
CURRENT ASSETS
Debtors
7
3,188
3,107
Cash at bank and in hand
265,137
479,327
---------
---------
268,325
482,434
CREDITORS: amounts falling due within one year
8
( 111,426)
( 266,227)
---------
---------
NET CURRENT ASSETS
156,899
216,207
---------
---------
TOTAL ASSETS LESS CURRENT LIABILITIES
157,456
216,930
---------
---------
NET ASSETS
157,456
216,930
---------
---------
CAPITAL AND RESERVES
Called up share capital
100
100
Profit and loss account
157,356
216,830
---------
---------
SHAREHOLDERS FUNDS
157,456
216,930
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 16 January 2024 , and are signed on behalf of the board by:
Dr N S Nicholas
Director
Company registration number: 07141314
GYNICARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 APRIL 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lynton House, 7 - 12 Tavistock Square, London, WC1H 9BQ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity. Revenue recognition Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably. Income tax The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Goodwill Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years. Amortisation Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill - Over 5 years
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates. Tangible assets Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. Depreciation Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment - 25% straight line
Impairment of fixed assets A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to Nil (2022: 3 ).
5. Intangible assets
Goodwill
£
Cost
At 1 May 2022 and 30 April 2023
145,080
---------
Amortisation
At 1 May 2022 and 30 April 2023
145,080
---------
Carrying amount
At 30 April 2023
---------
At 30 April 2022
---------
6. Tangible assets
Equipment
Total
£
£
Cost
At 1 May 2022
17,297
17,297
Additions
260
260
--------
--------
At 30 April 2023
17,557
17,557
--------
--------
Depreciation
At 1 May 2022
16,574
16,574
Charge for the year
426
426
--------
--------
At 30 April 2023
17,000
17,000
--------
--------
Carrying amount
At 30 April 2023
557
557
--------
--------
At 30 April 2022
723
723
--------
--------
7. Debtors
2023
2022
£
£
Other debtors
3,188
3,107
-------
-------
8. Creditors: amounts falling due within one year
2023
2022
£
£
Other creditors
111,426
266,227
---------
---------